Abstract
Visceral leishmaniasis (VL) is a parasitic disease that cause high morbidity and mortality worldwide. In the Americas is caused by Leishmania (Leishmania) chagasi, particularly affecting cells of the mononuclear phagocytic system. During active infection, both in man and in animal models, biochemical changes occur as a reduction in levels of high-density lipoproteins (HDL) and an increase…